000896717 001__ 896717
000896717 005__ 20220103172033.0
000896717 0247_ $$2doi$$a10.3390/molecules26051294
000896717 0247_ $$2ISSN$$a1420-3049
000896717 0247_ $$2Handle$$a2128/29098
000896717 0247_ $$2pmid$$a33673611
000896717 0247_ $$2WOS$$aWOS:000628431800001
000896717 037__ $$aFZJ-2021-03550
000896717 041__ $$aEnglish
000896717 082__ $$a540
000896717 1001_ $$0P:(DE-HGF)0$$aBerning, Lena$$b0
000896717 245__ $$aProdigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
000896717 260__ $$aBasel$$bMDPI$$c2021
000896717 3367_ $$2DRIVER$$aarticle
000896717 3367_ $$2DataCite$$aOutput Types/Journal article
000896717 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637661268_26757
000896717 3367_ $$2BibTeX$$aARTICLE
000896717 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000896717 3367_ $$00$$2EndNote$$aJournal Article
000896717 520__ $$aCisplatin-based treatment is the standard of care therapy for urothelial carcinomas. However, complex cisplatin resistance mechanisms limit the success of this approach. Both apoptosis and autophagy have been shown to contribute to this resistance. Prodigiosin, a secondary metabolite from various bacteria, exerts different biological activities including the modulation of these two cellular stress response pathways. We analyzed the effect of prodigiosin on protein levels of different autophagy- and apoptosis-related proteins in cisplatin-sensitive and -resistant urothelial carcinoma cells (UCCs). Furthermore, we investigated the effect on cell viability of prodigiosin alone or in combination with cisplatin. We made use of four different pairs of cisplatin-sensitive and -resistant UCCs. We found that prodigiosin blocked autophagy in UCCs and re-sensitized cisplatin-resistant cells to apoptotic cell death. Furthermore, we found that prodigiosin is a potent anticancer agent with nanomolar IC50 values in all tested UCCs. In combination studies, we observed that prodigiosin sensitized both cisplatin-sensitive and -resistant urothelial carcinoma cell lines to cisplatin treatment with synergistic effects in most tested cell lines. These effects of prodigiosin are at least partially mediated by altering lysosomal function, since we detected reduced activities of cathepsin B and L. We propose that prodigiosin is a promising candidate for the therapy of cisplatin-resistant urothelial carcinomas, either as a single agent or in combinatory therapeutic approaches
000896717 536__ $$0G:(DE-HGF)POF4-2171$$a2171 - Biological and environmental resources for sustainable use (POF4-217)$$cPOF4-217$$fPOF IV$$x0
000896717 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000896717 7001_ $$0P:(DE-HGF)0$$aSchlütermann, David$$b1
000896717 7001_ $$0P:(DE-HGF)0$$aFriedrich, Annabelle$$b2
000896717 7001_ $$0P:(DE-HGF)0$$aBerleth, Niklas$$b3
000896717 7001_ $$0P:(DE-HGF)0$$aSun, Yadong$$b4
000896717 7001_ $$0P:(DE-HGF)0$$aWu, Wenxian$$b5
000896717 7001_ $$0P:(DE-HGF)0$$aMendiburo, María José$$b6
000896717 7001_ $$0P:(DE-HGF)0$$aDeitersen, Jana$$b7
000896717 7001_ $$0P:(DE-Juel1)169140$$aBrass, Hannah$$b8$$ufzj
000896717 7001_ $$0P:(DE-HGF)0$$aSkowron, Margaretha A.$$b9
000896717 7001_ $$0P:(DE-HGF)0$$aHoffmann, Michèle J.$$b10
000896717 7001_ $$0P:(DE-HGF)0$$aNiegisch, Günter$$b11
000896717 7001_ $$0P:(DE-Juel1)128906$$aPietruszka, Jörg$$b12$$ufzj
000896717 7001_ $$0P:(DE-HGF)0$$aStork, Björn$$b13$$eCorresponding author
000896717 773__ $$0PERI:(DE-600)2008644-1$$a10.3390/molecules26051294$$gVol. 26, no. 5, p. 1294 -$$n5$$p1294 -$$tMolecules$$v26$$x1420-3049$$y2021
000896717 8564_ $$uhttps://juser.fz-juelich.de/record/896717/files/molecules-26-01294-v2.pdf$$yOpenAccess
000896717 909CO $$ooai:juser.fz-juelich.de:896717$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b0
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b1
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b2
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b3
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b4
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b5
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b6
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b7
000896717 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)169140$$aForschungszentrum Jülich$$b8$$kFZJ
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)169140$$a Heinrich-Heine-Universität Düsseldorf$$b8
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b9
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b10
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b11
000896717 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)128906$$aForschungszentrum Jülich$$b12$$kFZJ
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)128906$$a Heinrich-Heine-Universität Düsseldorf$$b12
000896717 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Heinrich-Heine-Universität Düsseldorf$$b13
000896717 9131_ $$0G:(DE-HGF)POF4-217$$1G:(DE-HGF)POF4-210$$2G:(DE-HGF)POF4-200$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-2171$$aDE-HGF$$bForschungsbereich Erde und Umwelt$$lErde im Wandel – Unsere Zukunft nachhaltig gestalten$$vFür eine nachhaltige Bio-Ökonomie – von Ressourcen zu Produkten$$x0
000896717 9141_ $$y2021
000896717 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000896717 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000896717 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOLECULES : 2019$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000896717 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000896717 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000896717 920__ $$lyes
000896717 9201_ $$0I:(DE-Juel1)IBOC-20090406$$kIBOC$$lInstitut für Bioorganische Chemie (HHUD)$$x0
000896717 9201_ $$0I:(DE-Juel1)IBG-1-20101118$$kIBG-1$$lBiotechnologie$$x1
000896717 980__ $$ajournal
000896717 980__ $$aVDB
000896717 980__ $$aUNRESTRICTED
000896717 980__ $$aI:(DE-Juel1)IBOC-20090406
000896717 980__ $$aI:(DE-Juel1)IBG-1-20101118
000896717 9801_ $$aFullTexts